Cancer Antibodies
Introduction of Cancer Research
Cancer research is a multidisciplinary field focused on understanding the development, progression, and treatment of cancer. It encompasses a wide array of studies, from investigating the genetic and molecular basis of cancer to exploring novel therapeutic strategies. Researchers in this domain strive to uncover the fundamental principles underlying the biology of cancer cells and their interactions with the surrounding environment.
Researchers in the field of cancer study the genetic mutations, cellular signaling pathways, and immune system interactions that drive cancer growth. By understanding the intricacies of cancer biology, we can gain profound insights into the development of targeted therapies, immunotherapies, and precision medicine approaches.
The impact of cancer research is immeasurable, influencing every aspect of oncology from early detection to survivorship. Breakthroughs in this field have led to the development of life-saving treatments, improved diagnostic methods, and innovative prevention strategies. Cancer research is at the forefront of efforts to improve patient outcomes and ultimately find cures for a wide range of malignancies.
With a catalog representing over 15,000 protein targets, trial sizes to explore blossoming projects, and enhanced validation methods, Aviva is committed to supporting researchers as they pave the way for more discoveries and breakthroughs in Cancer Research.
For pathways in cancer please click here
Featured Products
Sample Type: Mouse liver and N2a cell lysate GATA2 antibody - N-terminal region (ARP31855_T100) using mouse liver and N2a cell lysate in Western Blot, click here |
Sample Type: Human lung HEY1 Antibody - C-terminal region (ARP32512_T100) using human lung tissue lysate in Western Blot, click here |
Sample Type: Human lung HEY1 Antibody - C-terminal region (ARP32512_T100) using human lung tissue in IHC, click here |